EDS
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2026
2027
Harmony BiosciencesHBS-301
Clinical Trials (1)
Total enrollment: 258 patients across 1 trials
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
Start: Jun 2026Est. completion: Nov 2027258 patients
Phase 3Recruiting
Related Jobs
Associate Director/Director, Information Security
New York, NY
4w ago
$170K - $220K/yr
Specialty Account Manager, Symbravo (St. Paul, MN)
St. Paul, MN
1mo ago
$100K - $150K/yr
Specialty Account Manager, Symbravo (Springfield, MO)
Springfield, MO
1mo ago
$100K - $150K/yr
Specialty Account Manager, Auvelity (Annapolis, MD)
Annapolis, MD
3mo ago
$100K - $150K/yr
Specialty Account Manager, Auvelity (Rochester, NY)
Rochester, NY
3mo ago
$100K - $150K/yr
Specialty Account Manager, Auvelity (Springfield, MA)
Springfield, MA
4mo ago
$100K - $150K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 258 patients
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.